AU2024901720A0 - Pharmaceutical compositions and methods - Google Patents

Pharmaceutical compositions and methods

Info

Publication number
AU2024901720A0
AU2024901720A0 AU2024901720A AU2024901720A AU2024901720A0 AU 2024901720 A0 AU2024901720 A0 AU 2024901720A0 AU 2024901720 A AU2024901720 A AU 2024901720A AU 2024901720 A AU2024901720 A AU 2024901720A AU 2024901720 A0 AU2024901720 A0 AU 2024901720A0
Authority
AU
Australia
Prior art keywords
methods
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2024901720A
Inventor
Fergus BINNIE
Yuefeng Long
Christopher Ritchie
Zhen Shi
Peter SURMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Douglas Pharmaceuticals Ltd
Original Assignee
Douglas Pharmaceuticals Ltd
Filing date
Publication date
Application filed by Douglas Pharmaceuticals Ltd filed Critical Douglas Pharmaceuticals Ltd
Publication of AU2024901720A0 publication Critical patent/AU2024901720A0/en
Assigned to DOUGLAS PHARMACEUTICALS LIMITED reassignment DOUGLAS PHARMACEUTICALS LIMITED Request for Assignment Assignors: BINNIE, Fergus, DOUGLAS PHARMACEUTICALS LIMITED, LONG, YUEFENG, RITCHIE, CHRISTOPHER, SHI, ZHEN, SURMAN, Peter
Priority to CN202480060869.7A priority Critical patent/CN121909020A/en
Priority to US18/814,130 priority patent/US20250064816A1/en
Priority to PCT/NZ2024/050099 priority patent/WO2025042298A1/en
Priority to AU2024328164A priority patent/AU2024328164A1/en
Abandoned legal-status Critical Current

Links

AU2024901720A 2023-08-24 2024-06-07 Pharmaceutical compositions and methods Abandoned AU2024901720A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN202480060869.7A CN121909020A (en) 2023-08-24 2024-08-23 Pharmaceutical rectal suppository compositions, methods of treatment and/or methods of manufacture of 6-thioguanine
US18/814,130 US20250064816A1 (en) 2023-08-24 2024-08-23 Pharmaceutical rectal suppository compositions of 6-thioguanine, methods of treatment and/or methods of manufacturing
PCT/NZ2024/050099 WO2025042298A1 (en) 2023-08-24 2024-08-23 Pharmaceutical rectal suppository compositions of 6-thioguanine, methods of treatment and/or methods of manufacturing
AU2024328164A AU2024328164A1 (en) 2023-08-24 2024-08-23 Pharmaceutical rectal suppository compositions of 6-thioguanine, methods of treatment and/or methods of manufacturing

Publications (1)

Publication Number Publication Date
AU2024901720A0 true AU2024901720A0 (en) 2024-06-20

Family

ID=

Similar Documents

Publication Publication Date Title
CA3260587A1 (en) Fah-modulating compositions and methods
AU2024308906A1 (en) Compositions and methods of using pln-targeting antibody-oligonucleotide conjugates
AU2025901328A0 (en) Pharmaceutical compositions and methods
AU2024901720A0 (en) Pharmaceutical compositions and methods
AU2023902710A0 (en) Pharmaceutical compositions and methods
AU2022903010A0 (en) Pharmaceutical compositions and methods
HK40130462A (en) Pharmaceutical composition and use
CA3273940A1 (en) Pharmaceutical compositions containing doravirine and islatravir
AU2025902410A0 (en) Methods and compositions
CA3307498A1 (en) Pharmaceutical compositions and uses thereof
AU2024901759A0 (en) Methods and compositions
CA3304568A1 (en) Pharmaceutical compositions comprising maralixibat and uses thereof
AU2026901963A0 (en) Therapeutic methods and compositions and uses thereof
AU2026900846A0 (en) Therapeutic compositions and related methods
AU2025901184A0 (en) Therapeutic compositions and related methods
AU2024900070A0 (en) Therapeutic methods and related compositions
AU2024902868A0 (en) Pharmaceutical Formulations and Uses Thereof
CA3298574A1 (en) Therapeutic blood-acid-shifting compositions and methods
HK40121460A (en) Pharmaceutical compositions of mosunetuzumab and methods of use
AU2025904753A0 (en) Pharmaceutical compositions
AU2026900535A0 (en) Formulations and methods thereof
AU2025906699A0 (en) Novel Compositions and Methods
AU2024904210A0 (en) Novel compositions and methods
AU2024902723A0 (en) Anti-inflammatory compositions and methods
CA3299185A1 (en) Lair-2 and tnt-trap compositions and methods